Earlier this year, news broke about doctors in London curing blindness in children with a rare genetic condition.

Gene therapy companies have faced numerous setbacks over the last few years. What will it take for gene therapies to fulfill ...

Biopharmaceuticals represent another significant market segment, holding a dominant share of 44.2%. The increasing emphasis on biologics, gene therapies, and personalized medicine is fueling the ...

Sangamo Therapeutics has stacked up $18 million cash from Eli Lilly in a licensing deal that will let the pharma use the ...

Maria Lowe, Ph.D., associate vice president of Pharmaceutical Intelligence at Institute for Clinical and Economic Review ...

Analysts at Precedence Research expect the gene-editing market to grow 15.7% annually and reach $40.1 billion by 2034, ...

In a study co-led by the University of Maryland School of Medicine (UMSOM), researchers have identified a "master regulator" ...

If preclinical findings were translated into clinic, they could shorten CAR-T generation lead time to one day.

PLC (AIM: 4BB) (“4basebio”), a company which develops and commercializes the large-scale manufacture of synthetic DNA as well as nanoparticle delivery solutions, today announced that it has received ...

Head and neck cancers often begin in the mouth, throat, or voice box. They're among the most common cancers in the world, ...

Kanazawa University and colleagues have achieved a breakthrough in understanding sperm DNA packaging. Using high-speed atomic force microscopy (HS-AFM), they captured the real-time process of ...